Oestrus response
The oestrus response observed in the study was 70-80 per cent (Table 1). The oestrus response was observed in treated groups while, none of the cows in control group exhibited oestrusbehaviour. The prominent sign of oestrus was observed in groups fortified with MM+BPF. Similar to the present results,
Naikoo et al., (2016) and
Sahoo et al., (2016) reported oestrus response as 66% (Ovsynch) and 71% (MM + BPF supplementation), respectively. The 83.33% oestrus response following administration of kisspeptinin buffalo was observedby
Pottapenjera et al., (2018). However, no earlier work on effect of kisspeptin on oestrus response in cattle has been reported to our knowledge. The higher oestrus response observed in group II and IV might be due to nutritional supplementation prior to hormonal treatment. Minerals have been reported to have a beneficial role in endocrine system and play an important role in resumption of follicular growth
(Kor et al., 2013). The fortification might have increased the number of ovarian follicles and enhanced the follicular growth
(Ambrose et al., 2006; Colazo et al., 2009). The oestrus response in group III is attributed to administration of kisspeptin. The kisspeptin is known as potent secretagogue of GnRH which might be responsible for onset of cyclicity in anoestrus cows in the present study.
The duration of oestrus in the study ranged from 18.57 to 32.75 hrs. The duration of oestrus observed in group I and II was similar to earlier reports of
Dudi et al., (2017) and
Ratnaparkhi et al., (2020) using Ovsynch and fortified Ovsynch protocol, respectively. The prolong duration of oestrus in group III and IV might be attributed to lower dose (1.3 µg/kg) of kisspeptin used in the present investigation. In contrast, lesser duration of oestrus (22.50 hrs) was observed following administration of Kisspeptin (20 µg/kg) by
Pottapenjera et al., (2018) in buffaloes. The authors further elucidated that the kisspeptin induced LH release is short-term and lower than GnRH induced LH release. This might be the reason of prolong oestrus duration in Kisspeptin group as compared to Ovsynch group in our study.
Signs of oestrus
The various behavioural signs of oestrus observed in present investigation have been shown in Table 2. The number of cows showing bellowing, mounting, frequent urination, loss of appetite and restlessness behaviourwere higher in group II. While, sniffing of vulva and raised tail were observed higher in group I and IV, respectively. The observed physical signs of oestrus in cows have been presented in Table 3. The population of cows with congested and swollen vulva was found higher in group II and IV. The copious quantity of mucus discharge was found greater in cows treated under group II. The clinico-gynaecological changes noted in animals responding to treatment with different oestrus induction protocols have been reported in Table 4. On examination, the open cervix, uterine tonicity and presence of large follicles with soft consistency were found in all treated animals. However, the proportion of cows with good uterine tone and soft follicular consistency was greater in group II as compared to other groups.
The behavioural signs of oestrus were observed to be higher in groups supplemented with MM and BPF. The supplementation might have showed a beneficial effect on resumption of ovarian cyclicity in anestrus animals. It is well known that minerals serve as co-factors in the steroidogenesis and play an important role in resumption ovarian activity
(Smith and Akinbamijo, 2000). Similarly, feeding fat positively influence ovarian functions by enhancing the synthesis of steroidal hormones
(Rahbar et al., 2014). The better behavioural signs of oestrus following fortification might be due to large size of ovulatory follicle and higher oestradiol production. In the present study, fortification resulted in higher percentage of cattle showing positive clinico-gynaecological changes such as relaxed cervix, turgid uterus and presence of large follicles. The swollen vagina with congested mucosa was also observed better in groups supplemented with MM and BPF. Similarly, copious discharge of cervico-vaginal mucus was found in the aforementioned groups. The fortification might have evoked better gonadal stimulation that resulted in higher elevation of oestrogen level which could bring about more conspicuous changes in the genitalia. The vaginal mucus discharge recorded (50-75%) were comparable to 61.7% observed by
Negussie et al., (2002). In contrast,
Nevkar et al., (2012) observed 45 per cent cows with mucus discharge, congested vulvar mucosa and swelling of vulva following treatment with Ovsynch protocol.
The changes in the genitalia were observed to be more pronounced in group I and II as compared to III and IV. The Ovsynch treatment in Group I and II might have evoked better gonadal stimulation leading to higher oestrogen level which could bring about more conspicuous changes in the genitalia (
Roberts, 1971;
Salisbury and Vandemark, 1961). As the oestrogen secreted from Graafian follicle is the reason of gradual relaxation of cervix and increased uterine tonicity (
Jainudeen and Hafez, 1987). However, inferior results in Group III and IV treated animals might be due to low dose of kisspeptin
(Chaikhun-Marcou et al., 2019). Further, the clinico-gynaecological changes were more pronounced in cows supplemented with MM and BPF. The supplements might have positive influence on reproduction by altering both hormonal and gondal status
(Mattos et al., 2000; Smith and Akinbamijo, 2000).
Oestrogen concentration
The serum oestrogen concentration at various days of treatment in different treatment groups has been presented in Table 5. The level of serum oestrogen varied significantly between treatment protocols on 7
th, 9
th and 10
th with control group but remained similar (P>0.05) at day 0. The serum oestrogen concentration increased significantly (P<0.05) from day 0 to day 10 of treatment in all the treatment protocols. Except in group II and IV where serum oestrogen concentration was statistically non-significant on day 7 and 9. The level of oestrogen concentration was found higher in group II at day 7, 9 and 10. The oestrogen concentration was found statistically greater in group I and II as compared to group II and IV. However, the difference was non-significant (P>0.05) between corresponding groups.
The gradual increase in mean serum oestrogen concentration was observed from day 0 to day 10 in all treated groups. This might be due to 1
st GnRH or kisspeptin injection which might have caused emergence of new follicular wave pursuing into growth and development of dominant follicle. Highest level of serum oestrogen concentration recorded on day 10 in all treatment protocol might be due to presence of pre-ovulatory follicle. The concentration of oestrogen was highest in Ovsynch groups which are in conformity to oestrus response of the animals. Poor response in kisspeptin groups is again accounted to inappropriate dosage. The better steroid secretion and follicular development in fortified groups is indicated by higher oestrogen concentration in fortified groups as compared to non-fortified ones.
Progesterone concentration
The serum progesterone concentration at 0, 7, 9 and 10 day of treatment in various groups has been presented in Table 6. The serum progesterone level was found to be higher (P<0.05) on day 7 in group I, II, IV while the difference was non-significant (P>0.05) in group III and V. The progesterone concentration was statistically similar between various groups at day 0 and 9. The serum progesterone concentration on day 7 and 10 was higher (P<0.05) in group II and IV, respectively. The level of progesterone was observed to be gradually increased from day 0 to day 7 of treatment and the progesterone level was found to be significantly higher (P<0.01) in group I, II and IV. However, mean progesterone level was found not to differ significantly in different days of treatment in group III.
Increase in serum progesterone level observed in the present investigation upto day 7 might be due to formation of CL or luteinization of follicles present in the ovary following GnRH and Kisspeptin administration. The significant reduction in serum progesterone levels on day 9 and 10 might be due to parenteral administration of PGF
2α on day 7 of treatment protocol leading to CL lysis which caused physiological declination of progesterone. However, no significant change in the level of progesterone was observed in different days of treatment in group III indicating absence of CL formation or lutenization of follicle due to low secretion of LH. In agreement to the present study,
Chaikhun et al., (2019) reported that administration of kisspeptin at the dose rate of 1.3 µg/kg caused lower secretion of LH as compared to buserelin injection. Besides, kisspeptin at the dose rate of 20 µg/kg causes maximum elevation of LH
(Pottapenjera et al., 2018). Luteal activity as indicated by serum progesterone concentration on day 7 of treatment might be due lower dose of kisspeptin (1.3 µg/kg) which failed to cause ovulation or luteinization of follicles.
Pregnancy rate
In the present investigation, the overall pregnancy rate was recorded highest in group II followed by group III and IV. However, lowest pregnancy rate was observed in group I (Table 7). The difference in number of cows those conceived did not differ significantly at induced estrus, second and third cycle. The pregnancy rate in cows inseminated at induced oestrus was higher in Ovsynch protocol. This might effectively persuade to generate LH surge by pre-ovulatory follicle. It was clearly mentioned that GnRH induced LH response is higher as compared to kisspeptin induced protocol
(Pottapenjera et al., 2018; Chaikhun-Marcou et al., 2019). The lower dose of kisspeptin used in the study might have failed to generate LH surge
(Decourt et al., 2014; McGrath et al., 2016). The higher pregnancy rate was observed in kisspeptin treated cows inseminated at second oestrus. The reason of better pregnancy rate at subsequent oestrus is still unclear. However, we could suspect that under given dosage the kisspeptin has successfully onset the cyclicity and has sustained hormonal milieu with fruitful conception in subsequent oestrus.